Vericel Corporation (VCEL)
NASDAQ: VCEL · Real-Time Price · USD
56.50
+1.55 (2.82%)
Dec 20, 2024, 4:00 PM EST - Market closed
Vericel Employees
Vericel had 314 employees as of December 31, 2023. The number of employees increased by 9 or 2.95% compared to the previous year.
Employees
314
Change (1Y)
9
Growth (1Y)
2.95%
Revenue / Employee
$722,433
Profits / Employee
$11,299
Market Cap
2.79B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Bausch Health Companies | 20,270 |
Amedisys | 19,000 |
LifeStance Health Group | 9,325 |
Patterson Companies | 7,600 |
iRhythm Technologies | 2,000 |
Twist Bioscience | 923 |
ACADIA Pharmaceuticals | 598 |
Merus | 229 |
VCEL News
- 2 days ago - Vericel Corporation: Hard To Justify Current Valuation - Seeking Alpha
- 6 weeks ago - Vericel Corporation (VCEL) Q3 2024 Earnings Conference Call Transcript - Seeking Alpha
- 6 weeks ago - Vericel Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - Vericel to Report Third-Quarter 2024 Financial Results on November 7, 2024 - GlobeNewsWire
- 4 months ago - Vericel to Present at the Morgan Stanley Global Healthcare Conference on Friday, September 6, 2024 - GlobeNewsWire
- 4 months ago - Vericel Announces FDA Approval and Commercial Availability of MACI Arthro - GlobeNewsWire
- 4 months ago - Vericel Announces FDA Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Thermal Burns - GlobeNewsWire
- 4 months ago - Vericel to Present at the Canaccord Genuity Growth Conference on Wednesday, August 14, 2024 - GlobeNewsWire